Abstract: The invention relates to a device for extracorporeal blood treatment, comprising a blood treatment unit 1 that comprises at least one compartment 4. The invention further relates to a method for determining a hemodynamic parameter during an extracorporeal blood treatment by means of an extracorporeal blood treatment device. In order to determine the hemodynamic parameter, the conveying direction of the blood pump 10 is reversed from a “normal” blood flow to a “reversed” blood flow. In practice, it has been found that reversing the conveying direction of the blood pump for a measurement for determining a hemodynamic parameter carries the risk of blood clots reaching the patient, despite the dialyser holding back blood clots. The blood treatment device comprises an input unit 23 for inputting a time interval which can be specified by the user, taking into account the patient-specific and system-specific factors.

Abstract: The invention relates to a method and a system for the remote monitoring of a medical technical apparatus used, in particular in a closed patient treatment room, for the medical monitoring or treatment of a specific patient, in particular from outside the patient treatment room.

Abstract: The invention relates to the providing of hydrophobic and hydrophilic polymer-based hollow fiber membranes containing a water-insoluble antioxidant; in particular, the invention relates to the providing of hollow fiber membranes for the extracorporeal treatment of blood, wherein the hollow fiber membranes have improved biocompatibility relative to treatment blood, in particular improved complement activation and lower platelet loss vis-à-vis treatment blood. At the same time, the elution of hydrophilic polymers from the lumen of the hollow fiber membrane is reduced.

Abstract: A tube connection part adapted to accommodate a flexible tube made from a material comprising polyvinyl chloride, wherein said tube connection part comprises a sleeve adapted to form an overlapping region between said tube connection part and said tube, wherein an adhesion promoting agent is deposited on at least a subsection of a surface of said sleeve, characterized in that the adhesion promoting agent comprises a styrene-butadiene block copolymer.

Abstract: A pressure measuring line with a connector can be used to connect the pressure measuring line to a blood treatment apparatus, and to a membrane. In some embodiments, the pressure measuring line comprises at least two consecutive lumen sections, namely the first lumen section and the second lumen section. The first lumen section can include a first lumen geometry and the second lumen section can include a second lumen geometry. The first lumen geometry and the second lumen geometry can differ from each other in at least their diameters. Further, a monitoring method and devices can be used in conjunction with the pressure measuring lines.

Abstract: The present invention relates to a method of adding an anticoagulant to the blood of a patient, wherein the addition takes place in the form of a bolus, wherein the bolus application time B depends on the values TBV and CO, with TBV representing the blood volume of the patient and CO the cardiac output of the patient. The present invention furthermore relates to an apparatus for adding a coagulant to the blood of a patient.

Abstract: The invention relates to device (1) for measuring volumes of a liquid in a container (B) by means of measuring emitted high-frequency radiation, comprising control unit (C), a transmitter (TX), at least one first transmitting antenna (ANT_TX1) and at least one second transmitting antenna (ANT_TX2), at least one receiving antenna (ANT_RX1) and a receiver (RX), wherein the transmitter (TX) is configured to emit high-frequency radiation when in operation, wherein the first transmitting antenna (ANT_TX1) and the second transmitting antenna (ANT_TX2) are configured to emit high-frequency radiation during operation so that radiation can reach the container (B), wherein first receiving antenna (ANT_RX1) is configured to record high-frequency radiation reflected from the container (B), wherein the receiver (RX) is configured to take up the high-frequency radiation received by the receiving antenna (ANT_RX1), wherein the control unit (C) is configured to control the transmitters so that the transmitter (TX) emits high

Abstract: The present invention refers to a system and method for opening a concentrate container without the need for a human to directly handle the concentrate container and connecting the concentrate container to a blood treatment device. Aspects of the invention are directed to a container for concentrate and a blood treatment device.

Abstract: The present invention relates to a medical device having a transparent region and a label wherein a hot stamping film is located on the transparent region; and a thermal transfer film that in turn has a label is located on the hot stamping film, with the label having a different color than the hot stamping film. The invention furthermore relates to a method of applying a label to a medical device.

Abstract: The invention relates to a mobile selection system for selecting medical accessories comprising a control system, a user interface and a treatment cart. The treatment cart comprises a plurality of storage devices each having at least two storage areas for a respective accessory type. The control system thereby implements a selection method having the following method steps. The treatment identifier of the treatment to be performed is determined in one method step via the user interface. In a further method step, a plurality of accessory set parameters which characterize a medical accessory set are determined on the basis of an accessory database and on the basis of the treatment identifier of the treatment to be performed.

Abstract: The invention relates to a method of determining a permeation property of hollow-fibre membranes wherein the permeation property of the hollow-fibre membrane is determined on a hollow-fibre membrane bundle which has been introduced into a housing and has terminally open hollow-fibre membranes at a first end of the hollow-fibre membrane bundle and terminally closed hollow-fibre membranes at a second end of the hollow-fibre membrane bundle. The invention more particularly relates to a method of determining the ultrafiltration rate and/or the ultrafiltration coefficient of hollow-fibre membranes.

Abstract: A method is presented for checking the integrity of a hollow-fibre fluid filter, in particular a hollow-fibre dialyzer (1), which is constructed from a plurality of hollow fibres (15) enclosed by a membrane, with the steps of: perfusing the inside or outside of the hollow fibres (15) with a fluid, supplying the outside or inside of the hollow fibres (15) with a gas, wherein the gas has a higher pressure than the fluid, and determining a quantity of the gas which penetrates into the fluid through holes in the membrane. The method is characterized in that, after flowing through the hollow-fibre fluid filter (1), the fluid is channelled through a bubble trap (30), and in that a volume of gas (41) collecting in the bubble trap (30) during a predefined or predefinable reference period is determined. Furthermore, equipment for checking the integrity of a hollow-fibre fluid filter (1) is presented.

Abstract: The invention relates to a method for manufacturing a hollow fiber membrane bundle from a plurality of polysulfone and PVP-based hollow fiber membranes which encompasses the providing of a spinning solution comprising a polysulfone-based material, in particular polysulfone, a vinylpyrrolidone-based polymer, in particular polyvinylpyrrolidone, an aprotic solvent, in particular dimethylacetamide, providing a coagulant liquid comprising water and an aprotic solvent, in particular dimethylacetamide, co-extruding the spinning solution and the coagulant liquid through a concentric annular spinneret into a hollow strand, whereby the cavity of the strand is filled with coagulant liquid, conducting the strand through a precipitation gap, introducing the strand into a precipitating bath comprised substantially of water so as to obtain a hollow fiber membrane, conducting the hollow fiber membranes through at least one rinsing bath and drying the hollow fiber membrane obtained, arranging the resulting hollow fiber membra

Abstract: The invention relates to a method of detecting symptoms of peritonitis, wherein the method comprises the following steps: taking a photo of a drainage solution and/or of a catheter exit site using a smartphone and/or inputting at least one query parameter which is input by a patient through the input zone of a smartphone; and, evaluating the photo and/or the query parameter.

Abstract: The invention relates to a blood treatment device having an extracorporeal blood circuit which comprises an arterial line, a blood pump, a blood treatment unit and a venous line, wherein the arterial and venous lines can be connected to a blood vessel of a patient, and wherein the blood treatment device has an evaluation and control unit, wherein the evaluation and control unit is configured to carry out the following steps: (a1) determining the blood recirculation in a blood vessel of the patient connected to the extracorporeal blood circuit; and (b) calculating the blood flow in the blood vessel using the blood recirculation determined in accordance with (a1) and using a provided value or a value likewise previously determined for the cardiac output of the patient.

Abstract: The invention relates to an extracorporeal blood treatment device comprising a hydraulic system II comprising a plurality of flow paths, the blood treatment device having a control unit 40 which provides an operating mode for disinfecting the hydraulic system with a liquid which can be supplied via one of the flow paths. Moreover, the invention relates to a method for operating an extracorporeal blood treatment device with a hydraulic system comprising a plurality of flow paths. The blood treatment device according to the invention is characterized in that the hydraulic system II has a valve device 23 which provides several switching positions. The valve device 23 has an inlet 25A for the liquid for disinfecting the hydraulic system and a plurality of outlets 26A, 27A, 28A, wherein in a switching position the inlet 25A is connected to one of the outlets 26A, 27A, 28A and in another switching position the inlet is connected to a plurality of outlets 26A, 27A, 28A.

Abstract: The present invention relates to an apparatus for performing peritoneal dialysis, the apparatus comprising means for delivering dialysis fluid to the peritoneal cavity of a patient, a measurement device for measuring the fluid pressure of the delivered dialysis fluid and/or the fluid pressure in the peritoneal cavity, i. e. the intraperitoneal pressure and/or any pressure related thereto, and a control unit operably connected to said means and the measurement device, wherein the control unit is configured to effect an inflow or outflow phase encompassing a series of fill-and-measurement or drain-and-measurement steps, each step comprising delivering a predetermined quantity of dialysis fluid to the peritoneal cavity or draining a predetermined quantity of dialysis fluid from the peritoneal cavity and subsequently measuring and recording a pressure value.

Abstract: The invention relates to a dialysis machine having a fluid system that has an inflow line for providing fresh dialyzing solution to a dialyzer and an outflow line for removing used dialyzing solution from the dialyzer, wherein the fluid system has a balancing system arranged between the inflow and outflow lines to balance the fluid volumes flowing through the lines, and wherein the fluid system has an ultrafiltration line that branches off from the outflow line between the dialyzer and the balancing system and has an ultrafiltration pump to be able to remove a defined volume of used dialyzing solution from the balance, and wherein an additional balancing chamber is provided that is arranged in a section of the inflow line disposed between the balancing system and the dialyzer or in a section of the outflow line disposed between the dialyzer and the branching of the ultrafiltration line.

Abstract: This disclosure relates to a medical device including a hard part and a converter. The hard part has fluid paths for conducting a medical fluid through the hard part. The converter is arranged to measure a characteristic of the medical fluid while the medical fluid is present in one of the fluid paths. At least a section of the converter is applied or superimposed to the hard part by at least one additive application method.

Abstract: The invention relates to a detection apparatus and a method for detecting and manipulating a blood vessel under the skin of part of the body of a patient, which comprises a treatment chamber for accommodating the body part, a data processing control device, a vascular structure measuring device for detecting the position and/or dimensions of vascular structure data of the blood vessel in the treatment chamber by measurement, a vascular manipulation device for changing the position and/or dimension of the blood vessel, wherein the control device is designed to control the vascular manipulation device as a function of the vascular structure data.